Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and valuable…
Read More »Biohaven Ltd
There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders…
Read More »
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating…
Read More »
For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she…
Read More »
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and…
Read More »